Hepatocellular Carcinoma，Bispecific Antibodies, HAIC, Ramucirumab
1 clinical trials · Condition
◉ Watch Hepatocellular Carcinoma，Bispecific Antibodies, HAIC, Ramucirumab
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular Carcinoma (NCT06441019) | Fudan University | 2024-07-01 |
Track Hepatocellular Carcinoma，Bispecific Antibodies, HAIC, Ramucirumab automatically
Every clearance here is in the API, with alerts when new ones post.